[ASAP] Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with < sup > 131 < /sup > I ‑Labeling and SPECT Imaging

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00954

Source: Molecular Pharmaceutics - January 20, 2023 Category: Drugs & Pharmacology Authors: Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, Xiang Li, Wenhui Ma, Fei Kang, Mingru Zhang, and Jing Wang Source Type: research